TP53 and endometrial cancer: In addition, Yano et al. reported that the prognosis of low-grade endometrioid cancer with abnormal p53 expression is equivalent to that of high-grade endometrial cancer [11], and Puppo et al. reported that patients with low-grade endometrial cancer who exhibit abnormal p53 expression appear to have a higher risk of recurrence [12].